Your browser doesn't support javascript.
loading
Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain.
Condliffe, Daniel; Wong, Andrew; Troakes, Claire; Proitsi, Petroula; Patel, Yogen; Chouliaras, Leonidas; Fernandes, Cathy; Cooper, Jonathan; Lovestone, Simon; Schalkwyk, Leonard; Mill, Jonathan; Lunnon, Katie.
Afiliación
  • Condliffe D; Institute of Psychiatry, King's College London, London, UK.
  • Wong A; Institute of Psychiatry, King's College London, London, UK.
  • Troakes C; Institute of Psychiatry, King's College London, London, UK.
  • Proitsi P; Institute of Psychiatry, King's College London, London, UK.
  • Patel Y; Institute of Psychiatry, King's College London, London, UK.
  • Chouliaras L; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Fernandes C; Institute of Psychiatry, King's College London, London, UK.
  • Cooper J; Institute of Psychiatry, King's College London, London, UK.
  • Lovestone S; Institute of Psychiatry, King's College London, London, UK.
  • Schalkwyk L; Institute of Psychiatry, King's College London, London, UK.
  • Mill J; Institute of Psychiatry, King's College London, London, UK; Institute of Biomedical & Clinical Science, University of Exeter Medical School, University of Exeter, Devon, UK.
  • Lunnon K; Institute of Biomedical & Clinical Science, University of Exeter Medical School, University of Exeter, Devon, UK. Electronic address: k.lunnon@exeter.ac.uk.
Neurobiol Aging ; 35(8): 1850-4, 2014 Aug.
Article en En | MEDLINE | ID: mdl-24679604
Epigenetic processes play a key role in the central nervous system and altered levels of 5-methylcytosine have been associated with a number of neurologic phenotypes, including Alzheimer's disease (AD). Recently, 3 additional cytosine modifications have been identified (5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine), which are thought to be intermediate steps in the demethylation of 5-methylcytosine to unmodified cytosine. Little is known about the frequency of these modifications in the human brain during health or disease. In this study, we used immunofluorescence to confirm the presence of each modification in human brain and investigate their cross-tissue abundance in AD patients and elderly control samples. We identify a significant AD-associated decrease in global 5-hydroxymethylcytosine in entorhinal cortex and cerebellum, and differences in 5-formylcytosine levels between brain regions. Our study further implicates a role for epigenetic alterations in AD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Citosina / Epigénesis Genética / Enfermedad de Alzheimer Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Neurobiol Aging Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Citosina / Epigénesis Genética / Enfermedad de Alzheimer Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Neurobiol Aging Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos